EBioMedicine 2021;65:103242.ArticlePubMedPMC 35
When someone loses weight quickly, which is common when taking a GLP-1 medication, the breasts may become saggy or appear deflated
513,514 These signaling pathways suggest that GLP-1 and its receptor agonists may influence the progression of NASH through multiple mechanisms, providing several potential therapeutic targets including: FOXO1, a transcription factor that plays a critical role in regulating glucose and lipid metabolism
So in the pancreas, we know that it's primarily on the insulin producing cells, and then we also have them in the intestine where they're probably involved in regulating inflammation and really creating a much healthier gut
doi: 10.3390/jcm8111926 14
A personalized plan is provided after consultation